Fortrea Holdings Inc.
General ticker "FTRE" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $1.2B (TTM average)
Fortrea Holdings Inc. follows the US Stock Market performance with the rate: 53.5%.
Estimated limits based on current volatility of 6.0%: low 17.46$, high 19.70$
Factors to consider:
- Total employees count: 14300 (-7.7%) as of 2025
- North America accounted for 47.1% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Customer financing, Clinical trial recruitment, Business award delays, Regulatory and compliance, Third-party risks
- Earnings for 6 months up through Q2 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [12.83$, 26.11$]
- 2026-12-31 to 2027-12-31 estimated range: [12.39$, 24.93$]
Financial Metrics affecting the FTRE estimates:
- Positive: with PPE of 41.7 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Positive: 6.77 < Operating cash flow per share per price, % of 7.11
- Positive: 12.78 < Shareholder equity ratio, % of 20.75 <= 25.20
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: -0.14 < Investing cash flow per share per price, % of 0.90
Short-term FTRE quotes
Long-term FTRE plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $2,842.50MM | $2,696.40MM | $2,723.40MM |
| Operating Expenses | $2,810.50MM | $2,858.30MM | $3,596.00MM |
| Operating Income | $32.00MM | $-161.90MM | $-872.60MM |
| Non-Operating Income | $-62.50MM | $-113.10MM | $-110.40MM |
| Interest Expense | $69.70MM | $123.80MM | $91.40MM |
| Income(Loss) | $-30.50MM | $-275.00MM | $-983.00MM |
| Taxes | $1.20MM | $-3.50MM | $3.20MM |
| Other Income(Loss) | $6.50MM | $-57.00MM | $0.00MM |
| Net Income(Loss)* | $-25.20MM | $-328.50MM | $-986.20MM |
| Stockholders Equity | $1,714.10MM | $1,362.40MM | $563.50MM |
| Assets | $4,332.60MM | $3,579.20MM | $2,715.70MM |
| Operating Cash Flow | $168.40MM | $262.80MM | $113.50MM |
| Capital expenditure | $40.30MM | $25.50MM | $25.20MM |
| Investing Cash Flow | $-31.80MM | $251.60MM | $14.40MM |
| Financing Cash Flow | $-140.80MM | $-497.80MM | $-76.30MM |
| Earnings Per Share** | $-0.28 | $-3.67 | $-10.81 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.